AstraZeneca recently ranked second place overall in the pharmaceutical industry in the latest FTSE4Good Index, with an improved score of 4.7 from 4.1 in 2017. Ratings outperformed the sector average across all areas, particularly within the Environment and Social scores.
We are proud to be recognised again by the FTSE4Good Index. Our improved performance reflects our increasing sustainability focus as a company and our drive towards sustainable health.
FTSE4Good is designed to help investors identify socially responsible companies for investment opportunities. To be included in the index, companies must meet globally recognised corporate responsibility standards in five areas:
- Working toward environmental sustainability
- Upholding and supporting universal human rights
- Ensuring good supply chain labour standards
- Countering bribery and corruption
- Mitigating and adapting to climate change
Graph showing ranking against Industry and SubSector average:
Launched in 2001, the FTSE4Good Index Series is a series of benchmark and tradable indexes for ESG (Environmental, Social and Governance) investors. AstraZeneca has held a position on the FTSE4Good Index since its inception in 2001.